Pharming Group Q3 Revenue Rises 21%, Operating Profit Up 89%
Pharming reported preliminary unaudited Q3 revenue of $117.6 million, up 21% year over year, and operating profit of $29.9 million, up 89%. RUCONEST revenue rose 14% to $93.8 million; Joenja revenue grew 58% to $23.8 million.